SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-140361
Filing Date
2021-04-29
Accepted
2021-04-29 16:05:04
Documents
2
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d167512ddef14a.htm DEF 14A 300975
2 GRAPHIC g167512g42l66.jpg GRAPHIC 23852
  Complete submission text file 0001193125-21-140361.txt   332292
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-39527 | Film No.: 21870424
SIC: 2834 Pharmaceutical Preparations